Spotlight on the Future of GenericsGeneric drugs play a vital role in ensuring affordable access to healthcare and the future sustainability of medicines Share XViews & analysishttps://pharmaphorum.com/views-and-analysis/
Addressing global health challenges: the pharmaphorum podcastFor episode 11 of the pharmaphorum podcast our CEO and founder Dr Paul Tunnah took the helm to Share XAddressing global health challenges: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/iavi-global-health-challenges/
The science of prevention‘Prevention’ might be the buzzword of the moment in the pharma industry, but what does it actually mean Share XThe science of preventionhttps://pharmaphorum.com/r-d/views-analysis-r-d/the-science-of-prevention/
The rise and rise of digital health investmentFrom remote consultations to digital treatments, medical robotics to wellness apps, the digital health ecosystem is expanding like Share XThe rise and rise of digital health investmenthttps://pharmaphorum.com/views-analysis-digital/the-rise-and-rise-of-digital-health-investment/
There’s no I in T.E.A.M when it comes to healthcareAfter being diagnosed with a rare non-malignant brain tumour, Claire Snyman has dedicated herself to inspiring people to Share XThere’s no I in T.E.A.M when it comes to healthcarehttps://pharmaphorum.com/views-analysis-patients/theres-no-i-in-t-e-a-m-when-it-comes-to-healthcare/
Continuous bioprocessing – the key to industrialising gene therapy production?A new partnership, with funding from Innovate UK, aims to investigate the possibility of using continuous manufacturing processes Share XContinuous bioprocessing – the key to industrialising gene therapy production?https://pharmaphorum.com/r-d/views-analysis-r-d/continuous-bioprocessing-the-key-to-industrialising-gene-therapy-production/
ASCO 2019 round-upWith the American Society of Clinical Oncology (ASCO) conference over for another year, Richard Staines presents a round-up Share XASCO 2019 round-uphttps://pharmaphorum.com/spotlight/asco-2019-and-the-future-of-oncology/asco-2019-round-up/
Optimising market access for biosimilarsWe speak to Sandoz’s global head of biopharmaceuticals, Stefan Hendriks, about the remaining challenges in market access for Share XOptimising market access for biosimilarshttps://pharmaphorum.com/views-analysis-market-access/optimising-market-access-for-biosimilars/
Reimagining commercialisation with AIWe speak to Indegene’s Gaurav Kapoor to find out how he thinks pharma’s sales and marketing model needs Share XReimagining commercialisation with AIhttps://pharmaphorum.com/views-analysis-digital/reimagining-commercialisation-with-ai/
